Lamotrigin Syri Pharma

Lamotrigine, the active ingredient in Lamotrigin Syri Pharma, is an Anticonvulsant presented as an oral tablet for oral use. It is employed in the management of epilepsy and as a maintenance therapy for bipolar disorder, helping to control seizures and stabilize mood in adult patients, and is prescribed by neurologists and psychiatrists worldwide. The drug works by modulating neuronal excitability, which reduces the frequency of seizure episodes and mood swings.

GNH USA supplies Lamotrigin Syri Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is an anticonvulsant used to treat seizure disorders and mood stabilization in bipolar disorder.

- Partial seizures: reduces the frequency of focal seizure episodes. - Generalized tonic‑clonic seizures: decreases occurrence of convulsive seizures. - Bipolar disorder (maintenance): helps prevent recurrence of mood episodes. - Adjunct therapy in epilepsy: may be combined with other antiepileptic drugs to improve overall seizure control.

Lamotrigine may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects: - Dizziness: mild to moderate sensation of light‑headedness. - Headache: intermittent mild to moderate pain. - Nausea: occasional upset stomach. - Rash: mild skin irritation or erythema. - Insomnia: difficulty falling or staying asleep. - Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction requiring immediate discontinuation. - Toxic epidermal necrolysis: life‑threatening skin detachment. - Blood dyscrasias: agranulocytosis or aplastic anemia. - Hepatic failure: signs of liver dysfunction. - Suicidal ideation: new or worsening thoughts of self‑harm. - Severe hypersensitivity: anaphylaxis or angioedema.

When prescribing lamotrigine, clinicians should consider several safety measures.

- Dose titration: increase gradually to minimise rash risk. - Skin reactions: monitor for rash and discontinue if severe. - Psychiatric monitoring: watch for mood changes or suicidal thoughts. - Renal/hepatic impairment: adjust dosing as needed. - Pregnancy: risk unknown; weigh benefits against potential fetal risk. - Store at ambient temperature: keep in the original pack, protect from moisture.

Lamotrigine interacts with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Valproate: raises lamotrigine levels, increasing toxicity risk. - Carbamazepine: lowers lamotrigine levels, reducing therapeutic effect. - Phenobarbital: decreases lamotrigine concentrations, potentially compromising seizure control.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may increase lamotrigine levels, necessitating dose review. - Rifampin: can reduce lamotrigine concentrations, requiring monitoring. - Serotonergic agents: observe for signs of serotonin syndrome when combined.